Patents by Inventor Tobias SCHATTON

Tobias SCHATTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROGRAMMED CELL DEATH (PD-1) INHIBITOR THERAPY FOR PATIENTS WITH PD-1-EXPRESSING CANCERS
    Publication number: 20180231554
    Abstract: Described herein are biomarkers comprising mTOR, PI3K/AKT, and MAPK/ERK signaling pathway members as well as cap-dependent translation initiation factors that enable monitoring and predicting responses to PD-1 pathway blockade in patients afflicted with cancers characterized by PD-1 expression.
    Type: Application
    Filed: September 2, 2016
    Publication date: August 16, 2018
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Tobias SCHATTON, Sonja KLEFFEL, Christian POSCH